Shalini C. Reshmi

6.6k total citations · 1 hit paper
54 papers, 1.8k citations indexed

About

Shalini C. Reshmi is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Shalini C. Reshmi has authored 54 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 24 papers in Molecular Biology and 16 papers in Hematology. Recurrent topics in Shalini C. Reshmi's work include Genomic variations and chromosomal abnormalities (20 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Acute Lymphoblastic Leukemia research (13 papers). Shalini C. Reshmi is often cited by papers focused on Genomic variations and chromosomal abnormalities (20 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Acute Lymphoblastic Leukemia research (13 papers). Shalini C. Reshmi collaborates with scholars based in United States, Canada and Russia. Shalini C. Reshmi's co-authors include Susanne M. Gollin, Janet D. Rowley, Nancy J. Zeleznik‐Le, Julian Borrow, Brigitte Schlegelberger, Norman A. Doggett, Julie M. Gastier‐Foster, Richard D. Wood, John P. Wittschieben and David E. Housman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Shalini C. Reshmi

54 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group

2021 249 citations Julie M. Gastier‐Foster, Ruthann Pfau et al. profile →

Peers

Countries citing papers authored by Shalini C. Reshmi

Since Specialization

Citations

This map shows the geographic impact of Shalini C. Reshmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shalini C. Reshmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shalini C. Reshmi more than expected).

Fields of papers citing papers by Shalini C. Reshmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shalini C. Reshmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shalini C. Reshmi. The network helps show where Shalini C. Reshmi may publish in the future.

Co-authorship network of co-authors of Shalini C. Reshmi

This figure shows the co-authorship network connecting the top 25 collaborators of Shalini C. Reshmi. A scholar is included among the top collaborators of Shalini C. Reshmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shalini C. Reshmi. Shalini C. Reshmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinically significant findings in a decade‐long retrospective study of prenatal chromosomal microarray testing 2024 ·Molecular Genetics & Genomic Medicine ·(unknown), (unknown), Daniel C. Koboldt, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hui Mei, Ying‐Chen Claire Hou, Melanie Babcock, Jesse M. Hunter, Kathleen M. Schieffer, Yassmine Akkari, Shalini C. Reshmi, Catherine E. Cottrell, (unknown), Marco L. Leung	3
2	A Decade's Experience in Pediatric Chromosomal Microarray Reveals Distinct Characteristics Across Ordering Specialties 2022 ·Journal of Molecular Diagnostics ·(unknown), (unknown), Naveen Ramesh, Min Hu, (unknown), (unknown), Sayaka Hashimoto, (unknown), (unknown), Jesse M. Hunter, Shalini C. Reshmi, Matthew Schultz, Kristy Lee, Ruthann Pfau, Catherine E. Cottrell, Kim L. McBride, Nicholas E. Navin, Bimal P. Chaudhari, Marco L. Leung	3
3	Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder 2022 ·Molecular Case Studies ·Jesse M. Hunter, Lauren Massingham, Kandamurugu Manickam, Dennis Bartholomew, (unknown), (unknown), (unknown), (unknown), Emily de los Reyes, Shalini C. Reshmi, Catherine E. Cottrell, Richard K. Wilson, Daniel C. Koboldt	10
4	5′ <b><i>ALK</i></b> Amplification in Neuroblastoma: A Case Report 2021 ·Case Reports in Oncology ·Sara Akhavanfard, (unknown), (unknown), (unknown), Sayaka Hashimoto, (unknown), Ruthann Pfau, Marie‐Anne Bründler, Shalini C. Reshmi	2
5	Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors 2019 ·Pediatric Cardiology ·Jeffrey S. Bennett, (unknown), Kim L. McBride, Shalini C. Reshmi, Erik Zmuda, Naomi J. Kertesz, Vidu Garg, Sara Fitzgerald‐Butt, Anna Kamp	32
6	Pericentromeric regions of homozygosity on the X chromosome: Another likely benign population variant 2018 ·European Journal of Medical Genetics ·Elizabeth S. Barrie, Li Yu, (unknown), Sayaka Hashimoto, (unknown), (unknown), Robert E. Pyatt, Shalini C. Reshmi, Julie M. Gastier‐Foster, Ruthann Pfau, Caroline Astbury	1
7	Genomic analysis of adult B-ALL identifies potential markers of shorter survival 2017 ·Leukemia Research ·Shiven B. Patel, Clinton C. Mason, Martha Glenn, Christian N. Paxton, (unknown), Melissa H. Cessna, Julie Asch, Erin F. Cobain, Dale L. Bixby, Lauren B. Smith, Shalini C. Reshmi, Julie M. Gastier‐Foster, Joshua D. Schiffman, Rodney R. Miles	12
8	Atypical breakpoint in a t(6;17) translocation case of acampomelic campomelic dysplasia 2014 ·European Journal of Medical Genetics ·(unknown), Devon Lamb Thrush, Scott E. Hickey, Sayaka Hashimoto, Shalini C. Reshmi, Julie M. Gastier‐Foster, Robert E. Pyatt, Caroline Astbury	6
9	Characterization of copy number variation in genomic regions containing STR loci using array comparative genomic hybridization 2013 ·Forensic Science International Genetics ·Elena Repnikova, Jill A. Rosenfeld, (unknown), (unknown), (unknown), Aimee McKinney, (unknown), Sayaka Hashimoto, Devon Lamb Thrush, Caroline Astbury, Shalini C. Reshmi, Lisa G. Shaffer, Julie M. Gastier‐Foster, Robert E. Pyatt	6
10	12q14 microdeletion associated with HMGA2 gene disruption and growth restriction 2012 ·American Journal of Medical Genetics Part A ·(unknown), Robert E. Pyatt, (unknown), (unknown), (unknown), Aimee McKinney, Caroline Astbury, Shalini C. Reshmi, Kate Shane-Carson, Devon Lamb Thrush, Annemarie Sommer, Julie M. Gastier‐Foster	16
11	Microarray comparative genomic hybridization and cytogenetic characterization of tissue‐specific mosaicism in three patients 2012 ·American Journal of Medical Genetics Part A ·Elena Repnikova, Caroline Astbury, Shalini C. Reshmi, (unknown), Joan Atkin, Devon Lamb Thrush, Anna L. Mitchell, Robert E. Pyatt, Kristina M. Reber, Thomas P. Slavin, Julie M. Gastier‐Foster	17
12	Novel diagnostic features of dysferlinopathies 2010 ·Muscle & Nerve ·Xiomara Q. Rosales, Julie M. Gastier‐Foster, Sarah Lewis, Vinod Malik, Devon Lamb Thrush, Caroline Astbury, Robert E. Pyatt, Shalini C. Reshmi, Zarife Sahenk, Jerry R. Mendell	59
13	Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia 2009 ·Chemico-Biological Interactions ·Zhijian Qian, John M. Joslin, Thelma R. Tennant, Shalini C. Reshmi, David J. Young, Angela Stoddart, Richard A. Larson, Michelle M. Le Beau	63
14	Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification 2007 ·Cytogenetic and Genome Research ·Shalini C. Reshmi, Susanta Roychoudhury, Zichao Yu, Eleanor Feingold, D. Potter, W.S. Saunders, Susanne M. Gollin	19
15	Relationship between FRA11F and 11q13 gene amplification in oral cancer 2006 ·Genes Chromosomes and Cancer ·Shalini C. Reshmi, Xin Huang, David W. Schoppy, Robert C. Black, William S. Saunders, Jeremy C. Smith, Susanne M. Gollin	39
16	Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma 2005 ·Cancer Genetics and Cytogenetics ·James R. Cook, (unknown), Shalini C. Reshmi, Xin Huang, (unknown), Susanne M. Gollin, Susan L. Abbondanzo, Steven H. Swerdlow	16
17	Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line 2004 ·International Journal of Cancer ·Camille Ragin, Shalini C. Reshmi, Susanne M. Gollin	67
18	Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma 2004 ·Genes Chromosomes and Cancer ·Shalini C. Reshmi, William S. Saunders, (unknown), (unknown), Susanne M. Gollin	31
19	Increased Karyotype Precision Using Fluorescence In Situ Hybridization and Spectral Karyotyping in Patients with Myeloid Malignancies 1999 ·Cancer Genetics and Cytogenetics ·E. W. Fleischman, Shalini C. Reshmi, (unknown), (unknown), (unknown), (unknown), M A Frenkel, Janet D. Rowley	24
20	All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. 1997 ·Blood ·Janet D. Rowley, Shalini C. Reshmi, (unknown), (unknown), John Anastasi, Susana C. Raimondi, Nancy R. Schneider, Julio C. Barredo, Eduardo S. Cantú, Brigitte Schlegelberger, Frederick G. Behm, Norman A. Doggett, Julian Borrow, Nancy J. Zeleznik‐Le	168

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact